PlainRecalls
FDA Drug Moderate Class II Terminated

Lisinopril and Hydrochlorothiazide Tablets, 20 mg/25 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1264-01) and b) 1000-count tablets per bottle (NDC 0143-1264-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724.

Reported: January 30, 2013 Initiated: November 30, 2012 #D-132-2013

Product Description

Lisinopril and Hydrochlorothiazide Tablets, 20 mg/25 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1264-01) and b) 1000-count tablets per bottle (NDC 0143-1264-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724.

Reason for Recall

Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets.

Details

Units Affected
43,478 bottles
Distribution
Nationwide and Puerto Rico
Location
Eatontown, NJ

Frequently Asked Questions

What product was recalled?
Lisinopril and Hydrochlorothiazide Tablets, 20 mg/25 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1264-01) and b) 1000-count tablets per bottle (NDC 0143-1264-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724.. Recalled by West-ward Pharmaceutical Corp.. Units affected: 43,478 bottles.
Why was this product recalled?
Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 30, 2013. Severity: Moderate. Recall number: D-132-2013.